PARIS (Reuters) – France will take a stake in Sanofi (NASDAQ:)’s Opella by means of the Public Funding Financial institution (BPI), finance minister Antoine Armand stated on Sunday, confirming an data from Le Figaro newspaper that U.S. personal fairness agency Clayton Dubilier & Rice (CD&R) is to take a 51% stake within the firm that makes of one in every of France’s most-sold painkillers, Doliprane.
The plan for Public Funding Financial institution (BPI) to take a 1% stake in Opella, for about 150 million euros ($162.98 million), got here by means of a tri-party settlement between Sanofi, the French state and CD&R and was accredited by Sanofi’s board on Sunday, the newspaper stated.
Finance minister Antoine Armand had stated earlier this week that the federal government was all choices relating to Opella, together with the state being on Opella’s board of administrators.
($1 = 0.9204 euros)